foxo4-dri peptide senolytic mouse study 2023 2024

foxo4-dri peptide senolytic mouse study 2023 2024 regulates endothelial cell senescence via the P53 signaling pathway FOXO4 D-Retro-Inverso(DRI) peptide

Name: foxo4-dri peptide senolytic mouse study 2023 2024 regulates endothelial cell senescence via the P53 signaling pathway FOXO4 D-Retro-Inverso(DRI) peptide
Brand: equiscorp.hu
SKU: 90001658167
Price: 23.59 USD
Availability: InStock
Rating: 4.8226 (24 reviews)

FOXO4 D Retro Inverso(DRI) peptide FOXO4 DRI induces keloid senescent fibroblast apoptosis by promoting nuclear exclusion of upregulated p53 serine 15 phosphorylation Communications Biology foxo4 dri peptide senolytic mouse study 2023 2024 Molecular modelling of the FOXO4 TP53 interaction to design peptides for the elimination of senescent cancer cells FOXO4 DRI Peptide for Cellular Targeted Apoptosis of Senescent Cells Restores Tissue Homeostasis in Response to Chemotoxicity and Aging PMC

SKU: 90001658167 · From equiscorp.hu

4.8

USD23.59 USD66.59

Pay in 4 interest-free payments of $5.90 Learn more

Shipping Estimate
USA

USA

CAN

Ships within 48 hours · Estimated delivery Aug 2 - Aug 7

Description

reported -amino amide derivatives with an alternative Zinc chelating group

It is most often studied in animal models of tendon, gut, and vessel injury, and is not an FDA-approved drug

Key publications appear in the World Journal of Gastroenterology and Current Pharmaceutical Design, detailing the healing of ulcers, fistulas, and other GI injuries in animal models